Stockreport
Buy 5 Non-Tech Wide Moat Stocks to Strengthen Your Portfolio [Yahoo! Finance]
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
The business models of these companies possess durable competitive advantages that shield them from competitors. This strategy isn't just about recording short-term gains, but securing a portfolio of stocks that can weather economic storms and deliver stable and predictable returns. This investment strategy focuses on companies with unique strengths such as brand recognition, patent protection, proprietary technology and network effects. These moats ensure long-term profitability and market leadership, making the companies resilient in volatile markets. Here we recommend five non-tech Wide Moat stocks with a favorable Zacks Rank. These stocks are: Biogen Inc. BIIB, Lockheed Martin Corp. LMT, Northrop Grumman Corp. NOC, Mastercard Inc. MA and Mettler-Toledo International Inc. MTD. Each of our picks carries either a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here The chart below shows the price performance of our five picks year
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | BIIB | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
BIIB alerts
BIIB alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
NEWS
NEWS
- TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region [Yahoo! Finance][Yahoo! Finance]
- TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region[PR Newswire]
- Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region[GlobeNewswire]
- Biogen (BIIB) was upgraded by Piper Sandler from "neutral" to "overweight".[MarketBeat]
- Biogen (BIIB) had its price target lowered by Truist Financial Corporation from $193.00 to $189.00. They now have a "hold" rating on the stock.[MarketBeat]
- More
BIIB
SEC Filings
SEC Filings
- 4/6/26 - Form 8-K
- 4/3/26 - Form 4
- 3/31/26 - Form 8-K
- BIIB's page on the SEC website
- More